Author:
Sheetz Nicole,Wilson Brett,Benedict Joanne,Huffman Esther,Lawton Andy,Travers Mark,Nadolny Patrick,Young Stephen,Given Kyle,Florin Lawrence
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference21 articles.
1. ICH harmonised tripartite guideline, guideline for good clinical practice E6(R1). http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html. Accessed April 18, 2014.
2. Schuyl ML, Engel T. A review of the source document verification process in clinical trials. Drug Information Journal. 1999;33:789–797.
3. International Federations of Pharmaceutical Manufacturers and Associations. Clinical trials portal. http://clinical-trials.ifpma.org/clinicaltrials/en/tips/#s-link.
4. TransCelerate BioPharma Inc. Position paper: risk-based monitoring methodology. http://www.transceleratebiopharmainc.com/wp-content/uploads/2013/10/TransCelerate-RBM-Position-Paper-FINAL-30MAY2013.pdf. Published 2013.
5. Funning S, Grahnen A, Eriksson K, Kettis-Linblad A. Quality Assurance within the scope of good clinical practice (GCP): what is the cost of GCP-related activities? A survey within the Swedish Association of Pharmaceutical Industry (LIF)’s members. Qual Assur J. 2009;12:3–7.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献